Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Trading Up 0.4% – What’s Next?
by Renee Jackson · The Cerbat GemShares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC – Get Free Report) shot up 0.4% during mid-day trading on Thursday . The stock traded as high as $10.64 and last traded at $10.64. 353,815 shares changed hands during trading, an increase of 805% from the average session volume of 39,109 shares. The stock had previously closed at $10.60.
Analysts Set New Price Targets
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Oaktree Acquisition Corp. III Life Sciences in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.
Read Our Latest Analysis on Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences Stock Performance
The stock’s fifty day moving average is $10.60 and its two-hundred day moving average is $10.52.
Institutional Investors Weigh In On Oaktree Acquisition Corp. III Life Sciences
A number of institutional investors and hedge funds have recently modified their holdings of OACC. Meteora Capital LLC boosted its position in shares of Oaktree Acquisition Corp. III Life Sciences by 402.0% in the 3rd quarter. Meteora Capital LLC now owns 248,500 shares of the company’s stock valued at $2,612,000 after purchasing an additional 199,000 shares during the period. Verition Fund Management LLC lifted its stake in Oaktree Acquisition Corp. III Life Sciences by 6.7% during the third quarter. Verition Fund Management LLC now owns 161,740 shares of the company’s stock valued at $1,693,000 after buying an additional 10,117 shares in the last quarter. Clear Street Group Inc. acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the third quarter worth about $231,000. Berkley W R Corp increased its position in shares of Oaktree Acquisition Corp. III Life Sciences by 125.2% in the third quarter. Berkley W R Corp now owns 223,645 shares of the company’s stock worth $2,351,000 after acquiring an additional 124,315 shares in the last quarter. Finally, Shaolin Capital Management LLC increased its position in shares of Oaktree Acquisition Corp. III Life Sciences by 80.2% in the third quarter. Shaolin Capital Management LLC now owns 350,866 shares of the company’s stock worth $3,688,000 after acquiring an additional 156,104 shares in the last quarter.
About Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (“SPAC”) formed to pursue merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses in the life sciences sector. Incorporated as a Cayman Islands exempted company, OACC is sponsored by Oaktree Capital Management, a global alternative investment firm with a longstanding track record in credit strategies and private equity.